Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
about
Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapyNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Delivery of cancer therapeutics using nanotechnologyDiazepam-loaded solid lipid nanoparticles: design and characterization.Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicDevelopment of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid NanocapsulesCharacterization and in vivo evaluation of novel lipid-chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administrationFormulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa)Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.Differential scanning calorimetry techniques: applications in biology and nanoscienceSolid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Stabilization of food dispersions by enzymes.Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.A perspective overview on lipospheres as lipid carrier systems.Functional food microstructures for macronutrient release and delivery.Lipid nanoparticles for the topical delivery of retinoids and derivatives.Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis.Effect of squalane on mebendazole-loaded Compritol® nanoparticles.Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulationOptimization of artemether-loaded NLC for intranasal delivery using central composite design.New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell.Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies.
P2860
Q27027328-D03FE426-52D2-432C-96CB-7E32CC1C2696Q30354652-7170EF29-FE58-4F21-9194-BADADB5486CBQ30446963-7DD32F23-0001-4287-AC34-C1BB82E26606Q30478733-469DFBA4-3BD0-49A3-B235-C4520E3A4731Q30768284-6DCC06CC-E5BE-47EC-92BD-AC7EB4456689Q33529836-1B67FA45-ECD4-4701-82B3-4CE8847B27C5Q33544410-C0AFE5BB-E0AC-425F-972D-0F93CC3A5817Q33911056-94BC19E8-5733-4E48-A146-C63FF3FF4E87Q34160297-445E5152-1332-42CC-9F6F-3EF7C4D0D66CQ34205341-2421A53D-48A9-4DFD-833F-A1ABA0031BCBQ34440034-F497B888-60AF-436B-BA8B-767862D95490Q34444568-2390B7A8-510F-45F9-B1FB-C091FE8593BCQ34610568-75442DA0-795C-4A6F-954C-E892886820FEQ34999680-139BB3A8-3357-4415-AF6B-E051CFB16927Q36019637-B9E67176-4A51-4A73-9D36-CB2C502B1519Q36870135-97E2D166-04AF-4E70-90FA-4D4D58EB9485Q37044440-0B69BD53-D79C-4AB2-83A1-342A682D87E7Q37059900-51F192EB-B253-49CE-B66F-5C4A2CE34997Q37066550-B0804884-67E1-40C3-AB98-AD5AD45F34ECQ37146183-9210F448-D1AD-4286-B089-714034B52317Q37602960-7F50FAEB-3101-4158-A900-5B64332399F5Q37805491-3BEDB4CE-CF8D-444A-98A7-10CEF5164BD8Q37814131-1EFF0EAA-EC88-473D-9B47-AD3BA7486460Q38160303-2DAE2495-43ED-4019-B872-F970A7FD0CE5Q38178530-07E18FFD-9A69-4F58-A612-D3B9F44F55CAQ38207151-7788F58C-8036-4DFC-AA8F-B40FFADA81F9Q38242752-FC3C112B-044E-4DEE-A9B3-23FB2A03E2F6Q38252593-3F99FA14-3A9F-4334-BE56-C382841FC279Q38271617-60F680E5-CCA5-4442-BC10-2D2082271AB2Q38305635-97E15D08-8290-45DE-B9B9-15D4F41A072AQ38324016-872E8651-82F7-45EF-A7BA-59D1B12306B9Q38897966-8F4AE086-61AE-48D5-A141-B0313859C4FAQ38970111-D69636EA-EFC3-4FDB-A2C2-27ED5D2A9FF2Q38997074-17B304E8-3F29-40D8-9062-13201D4F5F10Q39008671-B3D0946F-12F2-4DF4-B370-54E8AB6F5461Q39025443-79531326-51B9-419A-914C-FCE4AA5D8455Q39176565-9F68AA53-7AF6-4523-8CFA-29579FC7D799Q39386696-5A06FBDD-2A40-4EA6-8030-3E1FD64C9A1EQ39518383-3142AFC3-D3B0-4599-8373-CC02600B36A0Q40158159-118CF2F3-1268-48D5-BB82-AABFE2A2B0C1
P2860
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterisation of a novel so ...... es of liquid and solid lipids.
@ast
Characterisation of a novel so ...... es of liquid and solid lipids.
@en
type
label
Characterisation of a novel so ...... es of liquid and solid lipids.
@ast
Characterisation of a novel so ...... es of liquid and solid lipids.
@en
prefLabel
Characterisation of a novel so ...... es of liquid and solid lipids.
@ast
Characterisation of a novel so ...... es of liquid and solid lipids.
@en
P2093
P1476
Characterisation of a novel so ...... es of liquid and solid lipids.
@en
P2093
P304
P356
10.1016/S0378-5173(00)00378-1
P407
P577
2000-04-01T00:00:00Z